Dr Wei Du

Fellow, DHSR&P
ANU College of Health and Medicine
T: +57492

Areas of expertise

  • Biostatistics 010402
  • Public Health And Health Services 1117
  • Pattern Recognition And Data Mining 080109
  • Epidemiology 111706

Research interests

Value-based healthcare, quality of life indicators, vulnerable populations, service use and outcome, science-policy-practice interface, applied statistics and machine learning, safety and disability, mental health, research translation


Dr Du is a medically trained biostatistician currently teaching survival analysis, coordinating Analysis of Public Health Data course, and working on quality, safety, and experience of medical and surgical interventions, value-based healthcare, service use and outcome in vulnerable populations with complex needs as well as pattern recognition and machine learning to inform systemic interventions. He participates in a number of research programs running in Australia and China. 

Dr Du is a member of the Editorial Board for the International Health (Oxford) and BMC Health Services Research (Springer). His strength mainly lies in study design and robust statistical application, as well as research to practice translation in both high and low income regions.

Researcher's projects

Healthcare service utilisation and health outcomes in persons with disabilities

Mental health outcomes and service utilisation among youth experiencing medication overdose

Variation in and factors associated with service use, cost, and outcomes

Evaluation of a General Practice Capability Building and Quality Improvement Initiative

Available student projects

Care and outcomes in vulnerable populations

Pattern recognition and machine learning using health data

Current student projects

Spatial temporal patterns of adverse drug events in NSW

Outcomes in relation to different patterns of service use

Socioeconomic inequalities in health care use, quality of care and outcomes 

Past student projects

Patterns of comorbidities in cancer survivors

Readmissions and mortality in relation to drug therapy for Acute Coronary Syndromes


Return to top

Updated:  14 November 2019 / Responsible Officer:  Director (Research Services Division) / Page Contact:  Researchers